Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03479463 · ClinicalTrials.gov registry record

Use of Human Dehydrated Amnion Chorion Allograft in Laryngectomy/Pharyngectomy

A clinical trial, sponsored by MiMedx Group.

Terminated
Registry status
8
Enrollment target

NCT03479463: Clinical Trial study, sponsored by MiMedx Group.

NCT03479463 is a clinical trial that was terminated before completion, run by MiMedx Group. The registered enrollment target is 8 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03479463 was terminated before completion, sponsored by MiMedx Group.

TERMINATED
Registry status
8 participants
Enrollment target

Study Summary

This trial aims to determine if intra-operative use of human dehydrated amnion chorion allograft improves post-operative patient healing outcomes.

Primary Outcome

Incidence of PCF developement necessitating intervention within the 60 day time point.

Interventions

  • BIOLOGICAL Dehydrated human amnion/chorion membrane

Trial Details

FieldValue
Enrollment Target 8 participants
Start Date 2018-03-19
Est. Completion 2019-03-30
MiMedx Group

32 total trials

Why NCT03479463 stopped before completion

NCT03479463 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 8 participants, a relatively small participant target.

The record links to 0 conditions, and to 1 intervention - of which Dehydrated human amnion/chorion membrane is the first listed.

NCT03479463 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT03479463 about?

NCT03479463 is a clinical study titled "Use of Human Dehydrated Amnion Chorion Allograft in Laryngectomy/Pharyngectomy". This trial aims to determine if intra-operative use of human dehydrated amnion chorion allograft improves post-operative patient healing outcomes.

What is the current status of trial NCT03479463?

This trial is currently terminated. The enrollment target is 8 participants. The study started on 2018-03-19. Estimated completion is 2019-03-30.

What interventions are being tested in trial NCT03479463?

The interventions under investigation include: Dehydrated human amnion/chorion membrane (BIOLOGICAL).

Who is sponsoring clinical trial NCT03479463?

This trial is sponsored by MiMedx Group, which has 32 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03479463, the US trial registry maintained by the National Library of Medicine. NCT03479463 (small enrollment · none site footprint · terminated) retrieved and formatted by PlainTrial, see methodology.